Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Permethrin For Lice Still Endorsed Despite Latest Resistance Research

This article was originally published in The Tan Sheet

Executive Summary

Continued use of permethrin as the front-line treatment for newly diagnosed infestations of head lice is advised by Harvard researchers despite new data showing some lice in the U.S. are resistant to the ingredient. Several OTC lice products, such as Warner-Lambert's Nix, contain permethrin as an active.

You may also be interested in...



Pediculicide Resistance Not Well Understood - Lancet Editorial

The mechanism by which head lice become resistant to pediculicides needs further study, Howard Maibach, MD, University of California at San Francisco, et al., suggest in the Aug. 12 issue of The Lancet.

Pediculicide Resistance Not Well Understood - Lancet Editorial

The mechanism by which head lice become resistant to pediculicides needs further study, Howard Maibach, MD, University of California at San Francisco, et al., suggest in the Aug. 12 issue of The Lancet.

Lice Class Action Lawsuit Discovery To Proceed On All Issues - Calif. Judge

Plaintiffs in a proposed California class action against four pediculicide manufacturers will be permitted to seek discovery on the merits of their claims that lice resistance to pesticides has rendered the companies' OTC products ineffective, a San Francisco state court judge ruled Oct. 13.

Topics

UsernamePublicRestriction

Register

LL1135495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel